HealthpointCapital Invests in Ospitek's Surgical Patient-Flow Software

HealthpointCapital announced an investment in Ospitek on October 13, 2026, with financial terms undisclosed. The San Diego company sells surgical operations and patient-flow intelligence software built around a system it calls VIEW, which uses IoT movement sensing, live visualization, automated communication and analytics to follow a patient through the surgical episode — registration, pre-operative preparation, the operating room and recovery — and to share that progress with staff, administrators and the families waiting for news.

The announcement gave no amount, valuation, ownership percentage or financing instrument, so no round label applies. HealthpointCapital did identify what it intends to support: technology-platform development, commercial operations, customer success and product innovation. CEO and cofounder Dr. Slim Souissi said the partnership would help bring Ospitek to more surgical facilities across the US.

The investor is a musculoskeletal healthcare private equity firm, and its specialization has a concrete commercial basis. Managing Partner Mike Mogul's official biography lists former roles as CEO of DJO Global and group president overseeing Stryker's orthopaedic businesses. HealthpointCapital also holds a separate investment in SteriCUBE, which addresses instrument sterilization and flow. Ospitek addresses the information following patients, placing the firm around different dependencies in surgical delivery — though no combined product or integration agreement was announced.

Ospitek's leadership page identifies three cofounders: Dr. Slim Souissi, Don Courtney and Dr. Munish Batra. The company lists Dr. Michael Ast as CMO and Heithem Souissi as VP of Product Engineering. Souissi's company biography describes a career in wireless technology, including former CTO and president/COO roles at Novatel Wireless, with work on mobile broadband and the MiFi hotspot. Batra's biography identifies him as a plastic and reconstructive surgeon, and Courtney's describes business-development experience across healthcare and wireless tracking. The company reports a 2018 founding date on LinkedIn.

On the product side, Ospitek's materials cover registration, pre-operative preparation, the operating room and recovery, along with analysis by surgeon, procedure and date range. The company positions VIEW as an overlay to existing systems — a deployment choice with commercial significance, since it means selling into facilities that already have established software and working habits. The source notes that sweeping claims about effortless deployment or guaranteed performance would require evidence beyond the company's marketing materials.

The public record leaves much private. There is no audited facility count, revenue or growth percentage, and the announcement supplied no investment-specific outcome data: pricing, spending allocations, hiring targets and expansion timetables are all unannounced. The available company history supports a business already addressing surgical workflows while leaving its financial scale largely undisclosed. What the deal does establish is that specialized healthcare capital is now behind the coordination surrounding a procedure — and that each additional facility will have to decide who sees which milestone, who follows up when movement slows, and how the record informs tomorrow's schedule.